Mouse models for xeroderma pigmentosum group A and group C show divergent cancer phenotypes

Joost P M Melis1, Susan W P Wijnhoven, Rudolf B Beems

  • 1National Institute of Public Health and the Environment (RIVM), Laboratory for Health Protection Research, Bilthoven, the Netherlands.

Cancer Research
|March 5, 2008
PubMed

Insights

DNA damage accumulation can cause aging and cancer. Nucleotide excision repair proteins Xeroderma pigmentosum group C (XPC) and A (XPA) have different functions. XPC deficiency significantly shortens lifespan and increases lung tumors, unlike XPA deficiency.

Area of Science:

  • Molecular biology
  • Genetics
  • Cancer research

Background:

  • DNA damage accumulation is linked to aging and cancer.
  • Nucleotide excision repair (NER) is a key defense mechanism.
  • Xeroderma pigmentosum group C (XPC) and group A (XPA) proteins are crucial NER components.

Purpose of the Study:

  • To investigate functional differences between XPC and XPA proteins.
  • To compare the impact of XPC and XPA deficiencies on mouse survival and tumor development.

Main Methods:

  • Survival studies in Xpa(-/-), Xpc(-/-), and wild-type female mice.
  • Analysis of tumor spectrum and mutant frequency in different organs.
  • In vitro studies using mouse embryonic fibroblasts (MEFs) to assess oxygen sensitivity.

Main Results:

  • Xpc(-/-) mice exhibited significantly reduced median survival compared to Xpa(-/-) and wild-type mice.
  • Xpc(-/-) mice showed a marked increase in lung tumors and elevated mutant frequency in lung tissue.
  • Xpa(-/-) mice displayed a significant increase in liver tumors.
  • Xpc(-/-) MEFs demonstrated heightened sensitivity to oxygen compared to Xpa(-/-) and wild-type MEFs.

Conclusions:

  • XPC plays a critical role in repairing oxidative DNA damage, particularly in lung tissue.
  • XPC deficiency leads to increased susceptibility to lung tumors and DNA mutations due to impaired oxidative damage repair.
  • XPA's role appears distinct, primarily associated with liver tumor development.